Tema ETF Trust Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) Dividend History

Dividend Yield: 1.54%

Dividend Frequency: Annually

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
December 12, 2024	$0.47	12/11/2024	12/11/2024

Company News

EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'

Novo Nordisk faces political pressure over high U.S. prices for its weight-loss drugs, Ozempic and Wegovy, ahead of the 2024 election. The company's CEO blamed pharmacy benefit managers (PBMs) for the high consumer costs, despite potential manufacturer price reductions.

Benzinga
ETFs to Profit from the Weight Loss Drug Boom

The market for GLP-1 drugs could soar to $130 billion by 2030

Zacks Investment Research

Featured Companies: LLY NVDA OZEM THNR TSLA

Page data last updated 09/07/2025 09:05:19 UTC Dividend yield is calculated using only dividends that have already been paid. Future or declared dividends are not included